These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4670729)

  • 21. [The association of kallikrein and inositol hexanicotinate in the therapy of peripheral obliterating arteriopathy].
    D'Ayala Valva G
    Recenti Prog Med; 1966 Jun; 40(6):XIX-XXXVI. PubMed ID: 6014405
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical and experimental studies on fibrinolysis activation].
    Bielawiec M
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst Suppl; 1967; 15():1-92. PubMed ID: 4953138
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical assessment of Cardilan].
    Markiewicz M; Korolko A
    Pol Tyg Lek; 1970 Nov; 25(47):1816-7. PubMed ID: 5484526
    [No Abstract]   [Full Text] [Related]  

  • 24. [Influence of xanthinol nicotinate on platelet agglutination test].
    Steger W
    Med Welt; 1973 Feb; 24(8):301-2. PubMed ID: 4688216
    [No Abstract]   [Full Text] [Related]  

  • 25. Prophylaxis of recurrent venous thrombosis with long-term enhancement of fibrinolysis.
    Bielawiec M; Lukjan H; Myśliwiec M; Dabrowski S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):971-6. PubMed ID: 94894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostaglandins in therapy of cardiovascular disease.
    Szczeklik A; Gryglewski RJ
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():345-54. PubMed ID: 3159222
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapeutic properties of xanthine nicotinate in the treatment of obliterating arteriopathies].
    Tardito E; Azzolini A; De Cristofaro A; Papacharalambus D
    Minerva Cardioangiol; 1972; 20(7):369-89. PubMed ID: 5050745
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacological fibrinolysis in occlusive vascular disease and its relation to diabetes mellitus.
    Fearnley GR
    Postgrad Med J; 1969 May; 45():52-62. PubMed ID: 5364315
    [No Abstract]   [Full Text] [Related]  

  • 29. Phenformin and ethyloestrenol for Raynaud's disease.
    Fearnley GR; Chakrabarti R
    Lancet; 1969 Oct; 2(7626):906-7. PubMed ID: 4186475
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of organic diseases of peripheral arteries with nicotinic acid derivatives].
    Liszewska D; Lukasik E
    Pol Tyg Lek; 1967 May; 22(21):794-6. PubMed ID: 6041002
    [No Abstract]   [Full Text] [Related]  

  • 31. [Activation of fibrinolysis after oral administration of D-glucitol-hexanicotinate. Preliminary data].
    Pinto A; Novo S; Avellone G; Vinci G
    Boll Soc Ital Cardiol; 1978; 23(4):641-5. PubMed ID: 757348
    [No Abstract]   [Full Text] [Related]  

  • 32. [Analysis of the pharmacodynamic properties of the nicotinic ester of 7-(2-hydroxyethyl)-theophylline. II. Cardiocirculatory effects in subjects with cerebral and peripheral angiopathies].
    De Gregorio G; Scaffidi L; Arcoraci A
    Cardiol Prat; 1971 Oct; 22(5):329-36. PubMed ID: 5136470
    [No Abstract]   [Full Text] [Related]  

  • 33. [The 131I-fibrinogen turnover during activation of blood fibrinolysis].
    Grabowski R; Bielawiec M; Kiersnowska B; Lukjan H; Perzanowski A; Mysliwiec M; Korfel B; Rogowski F
    Z Gesamte Inn Med; 1976 Dec; 31(24):1025-7. PubMed ID: 1020408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapy of peripheral obliterating arteriopathies with intra-arterial perfusions of dextran of low molecular weight and vasodilator agents].
    Buccellato C; Di Lorenzo GD
    Minerva Chir; 1967 Jun; 22(11):692-5. PubMed ID: 6050666
    [No Abstract]   [Full Text] [Related]  

  • 35. The influence of long-term therapy with phenformin plus metanabol on blood fibrinolytic activity, platelet adhesiveness and lipid metabolism in patients with arteriosclerosis.
    Perzanowski A; Bielawiec M; Myśliwiec M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):381-8. PubMed ID: 63425
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition of aggregation of human and rat platelets by fibrinolytic drug phenformin.
    Kovács IB; Csalay L; Görög P
    Angiology; 1972 Apr; 23(4):223-7. PubMed ID: 5030558
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of bencyclane in obliterative arterial diseases].
    Kusztos D
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1419+. PubMed ID: 5536658
    [No Abstract]   [Full Text] [Related]  

  • 38. [Application of bencyclane in arterial insufficiency of the lower limbs].
    Krylov VS; Zuravlev IV; Djacenko GM; Vychovskaja AA
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1433+. PubMed ID: 5536664
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effects of Sadamin and Complamin on left ventricular function].
    Dubiel JP; Bielecki A; Ciba T
    Pol Tyg Lek; 1973 Mar; 28(12):430-3. PubMed ID: 4695183
    [No Abstract]   [Full Text] [Related]  

  • 40. [New data on the use of halidor in obliterative diseases of arteries of the extremities].
    Zolotarevskiĭ VIa; Taranovich VA; Maksimova TV
    Klin Med (Mosk); 1969 Feb; 47(2):67-71. PubMed ID: 5379263
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.